Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
734.19M | 226.02M | 432.79M | 1.06B | 228.84M | Gross Profit |
706.78M | 193.40M | 380.64M | 990.62M | 176.30M | EBIT |
648.61M | 631.87M | -253.28M | 674.52M | 89.01M | EBITDA |
648.93M | 0.00 | -191.80M | 674.52M | 89.01M | Net Income Common Stockholders |
176.06M | 126.10M | -513.07M | 670.11M | 88.85M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
84.00M | 221.68M | 11.62B | 385.74M | 269.09M | Total Assets |
13.12B | 12.93B | 13.40B | 15.41B | 17.52B | Total Debt |
10.01B | 10.11B | 10.61B | 11.08B | 13.51B | Net Debt |
9.93B | 9.89B | 10.35B | 10.69B | 13.24B | Total Liabilities |
10.59B | 10.37B | 10.74B | 11.67B | 13.74B | Stockholders Equity |
2.53B | 2.56B | 2.67B | 3.74B | 3.78B |
Cash Flow | Free Cash Flow | |||
205.67M | 213.27M | 325.72M | 519.18M | 257.90M | Operating Cash Flow |
205.67M | 213.27M | 325.72M | 519.18M | 257.90M | Investing Cash Flow |
178.22M | 551.75M | 509.84M | 2.55B | 8.33B | Financing Cash Flow |
-521.58M | -807.94M | -956.70M | -2.95B | -8.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $9.36B | 10.99 | 9.58% | 14.09% | 384.69% | 963700.00% | |
68 Neutral | $12.38B | 13.21 | 8.40% | 12.14% | 13.33% | ― | |
65 Neutral | $1.25B | 9.30 | 11.08% | 11.54% | 139.84% | ― | |
64 Neutral | $1.12B | 12.57 | 6.92% | 10.28% | 7.13% | 64.82% | |
62 Neutral | $1.44B | 5.82 | 13.74% | 13.04% | 28.33% | ― | |
61 Neutral | $4.91B | 18.99 | -3.12% | 7.77% | 6.71% | -19.69% | |
58 Neutral | $527.79M | 13.23 | 8.19% | 18.71% | 137.36% | ― |
On March 3, 2025, Chimera Investment Corporation participated in the RBC Capital Markets Global Financial Institutions Conference, where it made available an investor presentation. The presentation, which was posted on the company’s website, provides insights into Chimera’s operations and strategic positioning, although it is not considered ‘filed’ for regulatory purposes.
On February 11, 2025, Chimera Investment Corporation announced the declaration of its first quarter dividends for several series of its preferred stocks, with payments scheduled for March 31, 2025. The dividends declared include $0.50 per share for Series A, $0.6488 per share for Series B, $0.484375 per share for Series C, and $0.6231 per share for Series D. This announcement highlights Chimera’s ongoing commitment to providing returns to its preferred shareholders, signaling stability and potential attractiveness to investors seeking consistent income in the real estate investment sector.
On January 31, 2025, Chimera Investment Corporation announced the sponsorship of CIM 2025-I1, a $287.7 million securitization of residential mortgage investor loans, with securities sold in a private placement to institutional investors. The securitization, rated by Fitch and Morningstar DBRS, reflects Chimera’s strategic move to enhance its real estate investment trust operations and strengthen its industry positioning by retaining subordinate interests and managing the assets through its subsidiary, Palisades Advisory Services.
Chimera Investment Corporation announced a cash dividend of $0.37 per common share for the fourth quarter of 2024, payable to shareholders on January 31, 2025. This move highlights the company’s commitment to returning value to shareholders and may impact its market positioning positively by reinforcing investor confidence.